Introduction
Platelet activating factor (PAF) was first identified as a biological mediator when its release was shown from sensitized rabbit basophils which had been stimulated by antigen. This (Fig. 3) . As before, intralymphatic PAF did not alter vascular pressures (Table 3 '4 In the PAF and phentolamine experiments, the intralymphatic infusion of PAF during phentolamine resulted in an increase in lymphatic perfusion pressure which was not different from that which was seen with this same dosage of PAF in the non-a-receptor blocked preparation (Fig. 1) 
